• LAST PRICE
    5.3600
  • TODAY'S CHANGE (%)
    Trending Down-0.0800 (-1.4706%)
  • Bid / Lots
    5.3600/ 4
  • Ask / Lots
    5.3700/ 4
  • Open / Previous Close
    5.2540 / 5.4400
  • Day Range
    Low 5.1750
    High 5.3900
  • 52 Week Range
    Low 2.6000
    High 9.9947
  • Volume
    213,894
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 5.44
TimeVolumeIBRX
09:32 ET265355.27
09:34 ET91205.26
09:36 ET25505.265
09:38 ET24235.28
09:39 ET3005.25
09:41 ET31005.29
09:43 ET144235.26
09:45 ET39005.23
09:48 ET53115.21
09:50 ET8005.22
09:52 ET13005.2011
09:54 ET10005.21
09:56 ET2005.215
09:57 ET16425.2
09:59 ET143975.18
10:01 ET15005.19
10:03 ET9005.19
10:06 ET13165.195
10:08 ET33885.22
10:10 ET39005.21
10:12 ET10005.215
10:14 ET12005.23
10:15 ET20225.22
10:17 ET20145.25
10:19 ET10005.25
10:21 ET42005.29
10:24 ET221445.34
10:26 ET33595.35
10:28 ET115515.3761
10:30 ET27005.35
10:32 ET24605.33
10:33 ET16005.33
10:35 ET3045.32
10:37 ET15365.31
10:39 ET19005.3
10:42 ET27375.33
10:44 ET33005.345
10:46 ET34445.36
10:48 ET26155.36
10:50 ET72955.378
10:51 ET47045.36
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIBRX
Immunitybio Inc
2.0B
-5.6x
---
United StatesVERV
Verve Therapeutics Inc
2.1B
-13.8x
---
United StatesPROK
ProKidney Corp
2.1B
-34.7x
---
United StatesISEE
IVERIC bio Inc
2.1B
-17.3x
---
United StatesRXRX
Recursion Pharmaceuticals Inc
1.8B
-8.1x
---
United StatesAXSM
Axsome Therapeutics Inc
1.8B
-11.8x
---
As of 2022-10-07

Company Information

Immunitybio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing therapies and vaccines that improve the immune system to defeat cancers and infectious diseases. Its immunotherapy and cell therapy platforms include antibody cytokine fusion proteins; synthetic immunomodulators; vaccine technologies, which includes human adenovirus (hAd5) viral vector, and genetically modified off-the-shelf natural killer cells (NK cells), which activate both the innate (NK cell and macrophage) and adaptive (T cell) immune systems. Its lead cytokine fusion protein, Anktiva, is an interleukin-15 (IL-15) superagonist complex. Its clinical pipeline consists of approximately 26 actively recruiting clinical trials of which 17 are in Phase II or III development, across 13 indications in liquid and solid tumors, including bladder, pancreatic, and lung cancers, and infectious diseases, including SARS-CoV-2 and human immunodeficiency virus (HIV).

Contact Information

Headquarters
3530 John Hopkins CtSAN DIEGO, CA, United States 92121-1121
Phone
858-633-0300
Fax
302-674-5266

Executives

Executive Chairman of the Board, Global Chief Scientific and Medical Officer
Patrick Soon-Shiong
President, Chief Executive Officer, Director
Richard Adcock
Chief Financial Officer
David Sachs
Director and Chief Corporate Affairs
Barry Simon
Independent Director
Michael Blaszyk

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.0B
Revenue (TTM)
$505.0K
Shares Outstanding
400.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.52
EPS
$-0.95
Book Value
$-0.61
P/E Ratio
-5.6x
Price/Sales (TTM)
3,939.6
Price/Cash Flow (TTM)
---
Operating Margin
-67,050.30%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.